Wei‐Chao Chang

1.8k total citations
39 papers, 736 citations indexed

About

Wei‐Chao Chang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei‐Chao Chang has authored 39 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei‐Chao Chang's work include SARS-CoV-2 and COVID-19 Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and CRISPR and Genetic Engineering (3 papers). Wei‐Chao Chang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and CRISPR and Genetic Engineering (3 papers). Wei‐Chao Chang collaborates with scholars based in Taiwan, United States and China. Wei‐Chao Chang's co-authors include Thomas R. Minor, Mien‐Chie Hung, Yung‐Luen Yu, Nancy K. Dess, Chi‐Chen Fan, Shao‐Chun Wang, Ching‐Chan Lin, Chen‐Yuan Lin, Ching-Yun Hsieh and Ling‐Chu Chang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Wei‐Chao Chang

37 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Chao Chang Taiwan 15 322 156 101 86 76 39 736
Mao‐Liang Chen Taiwan 18 388 1.2× 83 0.5× 133 1.3× 44 0.5× 112 1.5× 56 918
Anneleen Spooren Belgium 8 202 0.6× 72 0.5× 100 1.0× 62 0.7× 149 2.0× 8 662
Natalia Yanguas‐Casás Spain 14 301 0.9× 137 0.9× 91 0.9× 38 0.4× 177 2.3× 23 849
Ivan Nalvarte Sweden 20 544 1.7× 181 1.2× 69 0.7× 33 0.4× 106 1.4× 45 1.2k
Ana Guerra‐Librero Spain 17 486 1.5× 73 0.5× 57 0.6× 15 0.2× 61 0.8× 25 1.1k
Masato Mashimo Japan 15 747 2.3× 351 2.3× 140 1.4× 17 0.2× 213 2.8× 43 1.3k
Chuen‐Lin Huang Taiwan 15 224 0.7× 30 0.2× 119 1.2× 36 0.4× 26 0.3× 23 534
R. Maier Switzerland 19 505 1.6× 93 0.6× 230 2.3× 60 0.7× 356 4.7× 54 1.3k
Nazgol‐Sadat Haddadi Iran 14 166 0.5× 37 0.2× 89 0.9× 44 0.5× 98 1.3× 34 588

Countries citing papers authored by Wei‐Chao Chang

Since Specialization
Citations

This map shows the geographic impact of Wei‐Chao Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chao Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chao Chang more than expected).

Fields of papers citing papers by Wei‐Chao Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Chao Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chao Chang. The network helps show where Wei‐Chao Chang may publish in the future.

Co-authorship network of co-authors of Wei‐Chao Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Chao Chang. A scholar is included among the top collaborators of Wei‐Chao Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Chao Chang. Wei‐Chao Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wei‐Jan, Wan‐Jou Shen, Chung‐Yu Chen, et al.. (2024). Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula. Cancer Letters. 604. 217198–217198.
2.
Huang, Wei‐Chien, et al.. (2024). Stephania tetrandra and Its Active Compound Coclaurine Sensitize NSCLC Cells to Cisplatin through EFHD2 Inhibition. Pharmaceuticals. 17(10). 1356–1356.
3.
Chen, Chung‐Yu, et al.. (2024). Aqueous Extracts of Ocimum gratissimum Sensitize Hepatocellular Carcinoma Cells to Cisplatin through BRCA1 Inhibition. International Journal of Molecular Sciences. 25(15). 8424–8424. 1 indexed citations
4.
Chien, Yueh, Chih‐Ying Chen, Yi‐Ping Yang, et al.. (2024). Identifying Multiomic Signatures of X‐Linked Retinoschisis‐Derived Retinal Organoids and Mice Harboring Patient‐Specific Mutation Using Spatiotemporal Single‐Cell Transcriptomics. Advanced Science. 12(1). e2405818–e2405818. 2 indexed citations
5.
Hsieh, Ching-Yun, Ching‐Chan Lin, & Wei‐Chao Chang. (2023). Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma. Biomedicines. 11(11). 2887–2887. 7 indexed citations
6.
Chen, Hsiao‐Fan, Wei‐Jan Wang, Chung‐Yu Chen, et al.. (2023). The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2. eLife. 12. 14 indexed citations
7.
Peng, Shin‐Lei, Chung‐Yu Chen, Hsiao‐Fan Chen, et al.. (2023). Coffee as a dietary strategy to prevent SARS-CoV-2 infection. Cell & Bioscience. 13(1). 210–210. 7 indexed citations
8.
Zhao, Xixi, Yongkun Wei, Yu‐Yi Chu, et al.. (2022). Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function. Cancer Research. 82(11). 2185–2195. 36 indexed citations
9.
Yao, Chun‐Hsu, Yueh-Sheng Chen, Chih‐Yen Tu, et al.. (2022). Snail Mucus Enhances Chemosensitivity of Triple-negative Breast Cancer Via Activation of the Fas Pathway. Anticancer Research. 42(2). 845–855. 10 indexed citations
10.
Chiang, Hsiu‐Mei, Yeh Chen, Chung‐Yu Chen, et al.. (2022). Prospects of Coffee Leaf against SARS-CoV-2 Infection. International Journal of Biological Sciences. 18(12). 4677–4689. 13 indexed citations
11.
Hsieh, Ching-Yun, Ching‐Chan Lin, Yu-Wen Huang, et al.. (2022). Macrophage secretory IL-1β promotes docetaxel resistance in head and neck squamous carcinoma via SOD2/CAT-ICAM1 signaling. JCI Insight. 7(23). 35 indexed citations
13.
Huang, Sheng‐Teng, Yeh Chen, Wei‐Chao Chang, et al.. (2021). Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Viruses. 13(5). 826–826. 24 indexed citations
14.
Tsou, Yung‐An, Wei‐Chao Chang, Chia‐Der Lin, et al.. (2021). Metformin Increases Survival in Hypopharyngeal Cancer Patients with Diabetes Mellitus: Retrospective Cohort Study and Cell-Based Analysis. Pharmaceuticals. 14(3). 191–191. 9 indexed citations
15.
Fan, Chi‐Chen, Chen‐Yuan Lin, Ling‐Chu Chang, et al.. (2020). EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis. Redox Biology. 34. 101571–101571. 42 indexed citations
16.
Lin, Ching‐Chan, Yukai Huang, Wei‐Chung Cheng, et al.. (2020). Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression. Theranostics. 10(24). 10925–10939. 26 indexed citations
17.
Tu, Hung‐Pin, Chien‐Hui Hong, Wei‐Chao Chang, et al.. (2014). Female Gender and Acne Disease Are Jointly and Independently Associated with the Risk of Major Depression and Suicide: A National Population-Based Study. BioMed Research International. 2014. 1–7. 46 indexed citations
18.
Lin, H.‐J., et al.. (2009). Identification of the major TG4 cross‐linking sites in the androgen‐dependent SVS I exclusively expressed in mouse seminal vesicle. Journal of Cellular Biochemistry. 107(5). 899–907. 8 indexed citations
19.
Minor, Thomas R., et al.. (1994). Stress and adenosine: I. Effect of methylxanthine and amphetamine stimulants on learned helplessness in rats.. Behavioral Neuroscience. 108(2). 254–264. 33 indexed citations
20.
Minor, Thomas R., et al.. (1994). Stress and adenosine: II. Adenosine analogs mimic the effect of inescapable shock on shuttle-escape performance in rats.. Behavioral Neuroscience. 108(2). 265–276. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026